207 related articles for article (PubMed ID: 29029287)
1. Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer.
Prasongsook N; Kumar A; Chintakuntlawar AV; Foote RL; Kasperbauer J; Molina J; Garces Y; Ma D; Wittich MAN; Rubin J; Richardson R; Morris J; Hay I; Fatourechi V; McIver B; Ryder M; Thompson G; Grant C; Richards M; Sebo TJ; Rivera M; Suman V; Jenkins SM; Smallridge RC; Bible KC
J Clin Endocrinol Metab; 2017 Dec; 102(12):4506-4514. PubMed ID: 29029287
[TBL] [Abstract][Full Text] [Related]
2. Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer: A Single-Institution 21-Year Experience.
Wu SS; Lamarre ED; Yalamanchali A; Brauer PR; Hong H; Reddy CA; Yilmaz E; Woody N; Ku JA; Prendes B; Burkey B; Nasr C; Skugor M; Heiden K; Chute DJ; Knauf JA; Campbell SR; Koyfman SA; Geiger JL; Scharpf J
JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):300-309. PubMed ID: 36757708
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
Pezzi TA; Mohamed ASR; Sheu T; Blanchard P; Sandulache VC; Lai SY; Cabanillas ME; Williams MD; Pezzi CM; Lu C; Garden AS; Morrison WH; Rosenthal DI; Fuller CD; Gunn GB
Cancer; 2017 May; 123(9):1653-1661. PubMed ID: 28026871
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
Rao SN; Zafereo M; Dadu R; Busaidy NL; Hess K; Cote GJ; Williams MD; William WN; Sandulache V; Gross N; Gunn GB; Lu C; Ferrarotto R; Lai SY; Cabanillas ME
Thyroid; 2017 May; 27(5):672-681. PubMed ID: 28068873
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
Jannin A; Giudici F; de la Fouchardière C; Al Ghuzlan A; Wassermann J; Chougnet CN; Drui D; Godbert Y; Ilouz F; Bardet S; Zanetta S; Roudaut N; Batisse Lignier M; Groussin L; Klein M; Zerdoud S; Lamartina L; Baudin E; Decaussin-Petrucci M; Leteurtre E; Borson Chazot F; Do Cao C; Borget I; Hadoux J;
Thyroid; 2023 Oct; 33(10):1190-1200. PubMed ID: 37855745
[No Abstract] [Full Text] [Related]
6. Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment.
Jonker PKC; Turchini J; Kruijff S; Lin JF; Gill AJ; Eade T; Aniss A; Clifton-Bligh R; Learoyd D; Robinson B; Tsang V; Glover A; Sidhu S; Sywak M
Ann Surg Oncol; 2021 Nov; 28(12):7520-7530. PubMed ID: 34032961
[TBL] [Abstract][Full Text] [Related]
7. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy.
Foote RL; Molina JR; Kasperbauer JL; Lloyd RV; McIver B; Morris JC; Grant CS; Thompson GB; Richards ML; Hay ID; Smallridge RC; Bible KC
Thyroid; 2011 Jan; 21(1):25-30. PubMed ID: 21162687
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany.
Wendler J; Kroiss M; Gast K; Kreissl MC; Allelein S; Lichtenauer U; Blaser R; Spitzweg C; Fassnacht M; Schott M; Führer D; Tiedje V
Eur J Endocrinol; 2016 Dec; 175(6):521-529. PubMed ID: 27926471
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years.
Brignardello E; Gallo M; Baldi I; Palestini N; Piovesan A; Grossi E; Ciccone G; Boccuzzi G
Eur J Endocrinol; 2007 Apr; 156(4):425-30. PubMed ID: 17389456
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019.
Maniakas A; Dadu R; Busaidy NL; Wang JR; Ferrarotto R; Lu C; Williams MD; Gunn GB; Hofmann MC; Cote G; Sperling J; Gross ND; Sturgis EM; Goepfert RP; Lai SY; Cabanillas ME; Zafereo M
JAMA Oncol; 2020 Sep; 6(9):1397-1404. PubMed ID: 32761153
[TBL] [Abstract][Full Text] [Related]
11. Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
Iñiguez-Ariza NM; Ryder MM; Hilger CR; Bible KC
Thyroid; 2017 Jul; 27(7):923-927. PubMed ID: 28471306
[TBL] [Abstract][Full Text] [Related]
12. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
[TBL] [Abstract][Full Text] [Related]
13. Multimodality therapeutic outcomes in anaplastic thyroid carcinoma: improved survival in subgroups of patients with localized primary tumors.
Ito K; Hanamura T; Murayama K; Okada T; Watanabe T; Harada M; Ito T; Koyama H; Kanai T; Maeno K; Mochizuki Y; Amano J
Head Neck; 2012 Feb; 34(2):230-7. PubMed ID: 21500309
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
Fan D; Ma J; Bell AC; Groen AH; Olsen KS; Lok BH; Leeman JE; Anderson E; Riaz N; McBride S; Ganly I; Shaha AR; Sherman EJ; Tsai CJ; Kang JJ; Lee NY
Cancer; 2020 Jan; 126(2):444-452. PubMed ID: 31593317
[TBL] [Abstract][Full Text] [Related]
15. Anaplastic thyroid carcinoma: changing trends of treatment strategies and associated overall survival.
Wächter S; Vorländer C; Schabram J; Mintziras I; Fülber I; Manoharan J; Holzer K; Bartsch DK; Maurer E
Eur Arch Otorhinolaryngol; 2020 May; 277(5):1507-1514. PubMed ID: 32060602
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.
Sugitani I; Miyauchi A; Sugino K; Okamoto T; Yoshida A; Suzuki S
World J Surg; 2012 Jun; 36(6):1247-54. PubMed ID: 22311136
[TBL] [Abstract][Full Text] [Related]
17. Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study.
Chintakuntlawar AV; Rumilla KM; Smith CY; Jenkins SM; Foote RL; Kasperbauer JL; Morris JC; Ryder M; Alsidawi S; Hilger C; Bible KC
J Clin Endocrinol Metab; 2017 Jun; 102(6):1943-1950. PubMed ID: 28324060
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for Korean patients with anaplastic thyroid carcinoma.
Kim TY; Kim KW; Jung TS; Kim JM; Kim SW; Chung KW; Kim EY; Gong G; Oh YL; Cho SY; Yi KH; Kim WB; Park DJ; Chung JH; Cho BY; Shong YK
Head Neck; 2007 Aug; 29(8):765-72. PubMed ID: 17274052
[TBL] [Abstract][Full Text] [Related]
20. Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases.
Liu TR; Xiao ZW; Xu HN; Long Z; Wei FQ; Zhuang SM; Sun XM; Xie LE; Mu JS; Yang AK; Zhang GP; Fan Y
PLoS One; 2016; 11(10):e0164840. PubMed ID: 27760217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]